CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer
Study Number: 

I 286816

Phase: 
Early Phase
Principal Investigator: